Private Equity INSIGHT OUT Magazine June 2023
The pyramid hereunder illustrates several levels at which iNEDs (“independent non-executive directors”) can bring added value to the way a Board of Directors actually
functions, whether at the investment level or moving downwards into the portfolio company itself. The presence of iNEDs throughout the structure is now widely accepted
and welcomed, not just by other Board members but increasingly also by Regulators.
Issued in Private Equity INSIGHT OUT Magazine June 2023 pages 18-21
Tram is a multicultural internationally-minded C-suite Executive, certified Independent Non-Executive Director and a repeat tech company founder. She helps investors, boards and CEOs expand their geographic and services footprint, and extract the optimal value from their technology and human capital assets before maximizing exit opportunities.
28+ years of B2B operating leadership across North America, Europe and Asia in data-driven, service-oriented health, medical device, diagnostics, e-commerce & direct-to-consumer wellness platforms and SaaS/AI sectors. She has served in executive, advisory, and fiduciary board positions from large public Fortune 50, private mid and small caps, Private Equity Venture Capital or founder-owned companies.
She is praised by private company CEOs for governance oversight and by public company leaders for transitioning organizations into complex environments. and known for her relentless appetite to build and nurture relationships across disciplines and geographies, bringing to every relationship the highest mutual value, which has resulted in long-term trusted cross-border partnerships.
Educated in Western and Anglo-Saxon environments, she is a lifelong learner capable of stepping out of her comfort zone. She is known for her market insights lenses backed by a solid governance, financial and legal culture and brings a team player mindset that makes a difference in the boardroom.
She is passionate about inclusion and giving back to the next generations, serving on the Global Center for Risk and Innovation GCRI's Europe Industry Leadership Board to empower communities with innovative sustainability frameworks and tools to mitigate global risks and supporting Asterion Ventures' impact climate tech fund as Venture Partner.
As an inclusive leader, she has been interviewed and featured in four chapters of “The 5 Disciplines of Inclusive Leaders: Unleashing the Power of All of Us” a book released by Korn Ferry in 2020. As a mentor, she has received consistently an average rating of 9+ out of 10 by Endeavor Global scale-up CEOs.
She founded Vitanlink, a private holding focused on offering co-founding, pre-seed investment, post-seed advisory and fiduciary board services and operational interim execution. Companies out of North America, Europe, and Asia encompass SaaS and deep technology companies from a range of industries hospitality, MedTech, Digital Health or Financial Services, accelerators and investment funds. She has been recognized for her ability to deliver milestones under constrained timelines and fast-paced markets.
Tram served as a board member with a co-founded AI-powered Fintech and later as the Executive Vice President Ecosystems for the acquirer.
She led the recruitment of a new CEO, the pivot of the company business model from a B2B to a B2C and B2B2C strategy, and the company’s board decisions during the acquisition and transition process in 2021. She was instrumental in facilitating the company’s valuation outcome, multiplied by 3 from the date of the fintech incorporation and by 10 from the acquisition date. She served as an independent lead board director for another emerging growth AI in
healthcare company where she helped the board connect to and acquire a Fortune 100-listed MedTech US Group’s offer within 4 months.
Tram added value as a member of the EMEA Executive Board of Welch Allyn, owned since 2021 by Baxter International Inc (NYSE: BAX). She transformed the primary care eHealth market, products, and channel models, led the preparation, acquisition and transition of the French entity by a European distributor that paved the way for the later acquisitions of a $2B entity by a large listed company.
She assumed increasing levels of Profit and Loss accountability, ultimately serving as a member of the Johnson & Johnson OCD EMEA management board and expanding its international profitability growth and footprint for the $3 Billion JNJ’s IVD division, which led to a later successful spin-off to a large investment firm. She was awarded twice the Johnson & Johnson standards of leadership achievement.
Tram began her career as an EY auditor in Vietnam and Cambodia before moving to J&J (NYSE: JNJ) Ortho-Clinic Diagnostics.
Tram holds an MBA from McGill University, an active US Certified Public Accountant license [CPA New Hampshire State Board of Accounting], a certification in Private Company and Private Equity Portfolio Governance from the PDA, and the Financial Times Non-Executive Director Diploma. In addition to completing her King's College London LLM (Master of Laws), which enhances her risk management and corporate ESG governance skills, she regularly attends board director training and continuing education with various organizations such as the PDA, NACD and the FT NED Diploma or the Female Board Pool Europe. She is fluent in French (her native language) and English, has a professional command of German, and speaks Vietnamese.
aRTICLES & insights